An Approach to the Synthesis of a Hepatitis C Virus Inhibitor through a Proline-Catalyzed 1,3-Dipolar Cycloaddition Using Acrolein

Synthesis ◽  
2021 ◽  
Author(s):  
Luisa Carrillo ◽  
Jose L. Vicario ◽  
Iratxe Ugarriza ◽  
Efraím Reyes ◽  
Liher Prieto ◽  
...  

AbstractAn efficient and easy protocol for performing 1,3-dipolar cycloaddition using azomethine ylides and acrolein is presented. The reaction catalyzed by d-proline allows the synthesis of C-3 unsubstituted pyrrolidines. The application of this methodology to the synthesis of an advanced intermediate in the preparation of a Hepatitis C virus inhibitor is presented. Final attempts to complete the synthesis of the target inhibitor results in the preparation of its C-4 epimer in good overall yield.

2017 ◽  
Vol 28 (10) ◽  
pp. 1423-1429 ◽  
Author(s):  
Ihssene Chabour ◽  
Luis M. Castelló ◽  
Juan Mancebo-Aracil ◽  
María Martín-Rodríguez ◽  
María de Gracia Retamosa ◽  
...  

2011 ◽  
Vol 7 ◽  
pp. 988-996 ◽  
Author(s):  
María Martín-Rodríguez ◽  
Carmen Nájera ◽  
José M Sansano ◽  
Abel de Cózar ◽  
Fernando P Cossío

The synthesis of a GSK 2nd generation inhibitor of the hepatitis C virus, by enantioselective 1,3-dipolar cycloaddition between a leucine derived iminoester and tert-butyl acrylate, was studied. The comparison between silver(I) and gold(I) catalysts in this reaction was established by working with chiral phosphoramidites or with chiral BINAP. The best reaction conditions were used for the total synthesis of the hepatitis C virus inhibitor by a four step procedure affording this product in 99% ee and in 63% overall yield. The origin of the enantioselectivity of the chiral gold(I) catalyst was justified according to DFT calculations, the stabilizing coulombic interaction between the nitrogen atom of the thiazole moiety and one of the gold atoms being crucial.


2013 ◽  
Vol 43 (5) ◽  
pp. 235-239 ◽  
Author(s):  
Sergey M. Dibrov ◽  
Matthew A. Parker ◽  
B. Mikael Bergdahl ◽  
Thomas Hermann

2016 ◽  
Vol 52 (16) ◽  
pp. 3340-3343 ◽  
Author(s):  
Na Liu ◽  
Shiping Zhu ◽  
Xianghua Zhang ◽  
Xunkui Yin ◽  
Guoqiang Dong ◽  
...  

A novel anti-HCV benzothiazole scaffold was discovered by phenotypic screening. Further target characterization and structural optimization led to the identification of potent anti-HCV molecules targeting NS5A.


RSC Advances ◽  
2020 ◽  
Vol 10 (36) ◽  
pp. 21100-21107 ◽  
Author(s):  
Bassam Shaaban Mohammed ◽  
Amal E. Hamad ◽  
Sayed M. Derayea

Simeprevir is one of the newest direct action anti-hepatitis C drugs.


Sign in / Sign up

Export Citation Format

Share Document